Home' Australian Pharmacist : Australian Pharmacist December 2015 Contents Australian Pharmacist December 2015 I ©Pharmaceutical Society of Australia Ltd.
pharmacists eligible for FPS
PSA will recognise all members who become Advance Practice Pharmacists
by offering them the opportunity to become fellows of the society.
This will enable them to use the FPS
post nominal. The announcement came
after the results of the Credentialing of
Advanced Practice Pharmacists Pilot
Program were released last month.
National President of the PSA,
Joe Demarte, congratulated all the trial
participants and said all PSA members
who took part in the trial and who were
credentialed at the Advanced stage
would be eligible to become Fellows of
the Pharmaceutical Society and use the
FPS post nominals.
PSA Board member, Dr Chris Freeman
from Queensland was one of the 28
pharmacists credentialed as an Advance
He told Australian Pharmacist: 'I am
delighted to be credentialed as an
Advanced Practice Pharmacist, which
signals to my professional peers and
the patients whom I work with that I
am practising at the top of my scope
'Upon completing my portfolio, it
was valuable to both reflect on the
impact of my achievements and also
to consider which areas I have scope
for improvement. I would encourage
all pharmacists in all areas of practice
to consider the advanced practice
framework as both a tool for career
direction and as a way to acknowledge
The Australian Pharmacy Council (APC)
has been undertaking the pilot, which
uses the Advanced Pharmacy Practice
Framework (APPF) for Australia as a tool
for evaluating practitioner performance
and guiding development.
The pharmacists taking part in the pilot
program demonstrated the impact of
their practice through a portfolio of their
training, achievements and experience.
'This is a major step forward for the
pharmacy profession and is the
culmination of many years of hard
work to create a career framework for
pharmacists,' Mr Demarte said.
The pilot used the Advanced Pharmacy
Practice Framework (APPF) for Australia
as a tool for evaluating practitioner
performance and guiding development.
The participating pharmacists
demonstrated the impact of their
practice via a portfolio of their training,
achievements and experience. Each
portfolio was independently evaluated by
panels of trained credentialing evaluators.
Australian Pharmacy Council President,
Debra Rowett said: 'This pilot represents
a substantial commitment by APC to the
broader community, and I would like to
thank all those people involved. APC will
now be undertaking further evaluation
of the pilot.'
A total of 67% of the pilot participants
were evaluated at Advanced -- Stage 3
(credential level) and 33% of the
participants were evaluated at Advanced
-- Stage 2 (consolidation level).
Inaugural Chair of the APC Credentialing
Committee, Dr Ian Coombes, said:
'The pilot program is a fantastic
foundation for the future of formal
professional development and
recognition of pharmacists in Australia.'
Dr Shane Jackson, a member of APC's
Credentialing Committee and also
Chair of the Pharmacy Practitioner
Development Committee (PPDC) that
developed the APPF said: 'What a
journey! It has been extremely satisfying
to see the profession first develop an
advanced practice framework in 2012,
and then show it can be used in a
constructive way to evaluate practitioner
performance and support professional
development and ultimately, recognise
the achievements of the practitioner.'
innovation at PSA16
The Pharmaceutical Society of Australia's
national conference, PSA16, will be held
at Sydney's most exciting new hotel
and convention space -- Four Points by
Sheraton, Darling Harbour in July 2016.
The venue was announced at a the
launch of PSA16 in Sydney last month.
At the launch, PSA National President
Joe Demarte said that PSA16 would
continue to lead pharmacy innovation,
understanding that the future of the
profession and the industry was in
innovation, diversity, and expanded and
new models of practice.
'At PSA15 we redefined the framework
and context of professional practice
events. With PSA15 we set about leading
pharmacy innovation and created a
showcase event to inspire the profession
with new directions and opportunities,'
Mr Demarte said.
'It also created unparalleled
engagement levels between industry
partners and pharmacists to deliver
quality use of medicines to consumers
by empowering pharmacists to
recommend products and services
PSA Chief Executive Officer Dr Lance
Emerson said that the PSA had listened
to the valuable feedback the industry
provided from PSA15.
'You told us that the delegate
engagement at PSA15 was like no
other, with delegates interested in your
products and services, to take back with
them to their practice and help them
make a difference to their patients,'
Dr Emerson said.
PSA NSW Branch Director and PSA16
Chairman Steven Drew said the PSA16
program would enhance the latest in
clinical education and engage and spark
new directions in pharmacy.
PSA16 will run from 29--31 July 2016 and
will be held at Four Points by Sheraton,
Darling Harbour, Sydney.
Links Archive Australian Pharmacist November 2015 Australian Pharmacist January 2016 Navigation Previous Page Next Page